KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group
The Manipal Group is a leading conglomerate in India with various institutions and major businesses across the healthcare, education, and health insurance sectors, including Manipal Health Enterprises, one of India's top multispecialty hospitals chains in India.
KKR's Asia Pacific Credit platform seeks to provide, among other private credit strategies, bespoke solutions to high-quality companies, entrepreneurs, promoters and sponsors that harness the strength of KKR's private markets investment capabilities and its expertise as one of the largest alternative credit managers globally.
Gaurav Trehan, Co-Head of KKR Asia Pacific and Head of Asia Private Equity, KKR said, 'We are pleased to deepen our relationship with the Manipal Group and Dr Ranjan Pai, who have established one of India's pre-eminent and homegrown businesses, as they continue to deliver on their long-term vision. The Manipal Group has built a strong reputation over the decades as one of India's healthcare and education leaders, and we look forward to supporting and contributing to their continued success.'
Dr. Ranjan Pai, Chairman of Manipal Education and Medical Group, said, 'We are proud to welcome KKR as a strategic partner as we continue to build on Manipal's legacy in healthcare and education. KKR's longstanding India focus and flexible capital approach, as well as alignment with our long-term vision, present a strong fit for us.'
Diane Raposio, Partner and Head of Asia Credit and Markets at KKR, added, 'This transaction underscores the strength of our global credit platform and our ability to provide strategic, scaled capital solutions to leading businesses. India is a priority market for our credit strategy, and we look to build on this momentum to be a partner of choice to more high-quality companies like Manipal on their growth ambitions.'
KKR is making its investment from its Asia Pacific Credit strategy and insurance platform. Since 2019, KKR has committed more than $8 billion across around 60 credit investments under its Asia Pacific Credit strategy, accounting for a total transaction volume of more than $21 billion.
Additional details of the transaction are not disclosed.
About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at www.globalatlantic.com.
Founded in 1953 by Padma Shri Dr TMA Pai, MEMG has evolved into a diversified conglomerate, with a strong presence in healthcare, education and health insurance in India and globally. MEMG's operations touch the lives of over 20 million people annually with Manipal Hospitals scaling up to become the largest tertiary network in India. MEMG's flagship University, Manipal Academy of Higher Education has been recognized as an Institute of Eminence by the Government of India. Claypond Capital, the family office of Dr. Pai and the investing arm of MEMG has been one of the more prolific investing family offices in India in the last 18 months. Their marquee investments include Aakash, BPL Medical, BlueStone, Easy Home Finance, First Cry, Finnable, InCred Finance, NSE, Panacea Medical, PharmEasy, Purpple, Recykal, SSI Innovations and Zepto.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
13 hours ago
- Bloomberg
Private Equity Funds Traded in London Hint at Hidden 401(k) Risk
Private equity is moving closer to gaining entry into 401(k) accounts, but there's no clear picture of how retail investments in the asset class will fare. The big publicly listed names — Apollo, Blackstone, KKR — tell one story, but in their case, it's about the business of managing funds, not the actual returns inside them. Another perspective comes from one corner of the London Stock Exchange. There, buyout portfolios change hands every day, offering a rare, unvarnished read on private equity's market value. The verdict from a new study: When these assets are exposed to live pricing, they swing harder, trade at deep discounts to their stated value and struggle to match public markets over time.
Yahoo
a day ago
- Yahoo
KKR Drops $3B Bomb on Flexera -- Dividend, Debt, and a Power Play in Private Credit
KKR (NYSE:KKR) is stepping in with a heavyweight $3 billion private credit deal to help Thoma Bravo-owned Flexera Software clean up its capital stackand send some cash back to shareholders. The package includes a $2.03 billion term loan, a 590 million ($689 million) euro tranche, and a $150 million revolver. Sources say KKR's credit division is anchoring the deal, alongside Ares, Blackstone, Golub, HPS, and even Thoma Bravo's own credit arm. The loans are priced at 4.75 percentage points over respective benchmarksa premium in today's market, but possibly worth it for the flexibility on offer. Warning! GuruFocus has detected 8 Warning Signs with KKR. High Yield Dividend Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to calculate the intrinsic value of a stock? The big draw? Leverage. Private credit shops are dangling higher debt limits to keep deals from drifting back to traditional banks, where rates might be better but strings are often tighter. In Flexera's case, the new capital refinances a $1.95 billion syndicated loan due in 2028and adds nearly $1 billion of incremental debt, according to Bloomberg. That gives Flexera room to maneuver, whether that means strategic M&A or simply writing a dividend check to its sponsor. This isn't a one-off for Thoma Bravo. Back in April, it tapped direct lenders for $4 billion to back its Jeppesen buyout from Boeing. The firm seems to be leaning into the private credit playbook: speed, certainty, and structure over price. In a market where banks are fighting to claw back market share, this Flexera deal could be a signal that for some sponsors, the extra leverage and control are still worth the premium. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
KKR Drops $3B Bomb on Flexera -- Dividend, Debt, and a Power Play in Private Credit
KKR (NYSE:KKR) is stepping in with a heavyweight $3 billion private credit deal to help Thoma Bravo-owned Flexera Software clean up its capital stackand send some cash back to shareholders. The package includes a $2.03 billion term loan, a 590 million ($689 million) euro tranche, and a $150 million revolver. Sources say KKR's credit division is anchoring the deal, alongside Ares, Blackstone, Golub, HPS, and even Thoma Bravo's own credit arm. The loans are priced at 4.75 percentage points over respective benchmarksa premium in today's market, but possibly worth it for the flexibility on offer. Warning! GuruFocus has detected 8 Warning Signs with KKR. High Yield Dividend Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to calculate the intrinsic value of a stock? The big draw? Leverage. Private credit shops are dangling higher debt limits to keep deals from drifting back to traditional banks, where rates might be better but strings are often tighter. In Flexera's case, the new capital refinances a $1.95 billion syndicated loan due in 2028and adds nearly $1 billion of incremental debt, according to Bloomberg. That gives Flexera room to maneuver, whether that means strategic M&A or simply writing a dividend check to its sponsor. This isn't a one-off for Thoma Bravo. Back in April, it tapped direct lenders for $4 billion to back its Jeppesen buyout from Boeing. The firm seems to be leaning into the private credit playbook: speed, certainty, and structure over price. In a market where banks are fighting to claw back market share, this Flexera deal could be a signal that for some sponsors, the extra leverage and control are still worth the premium. This article first appeared on GuruFocus.
